ArticleActa neuropathologica communications2024

Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation.

J Steininger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.